Rationale and design of the 500-patient, 3-year, and prospective Vigilant ObservatIon of GlIadeL WAfer ImplaNT registry.

about

Rationale and design of the 500-patient, 3-year, and prospective Vigilant ObservatIon of GlIadeL WAfer ImplaNT registry.

Item

http://www.wikidata.org/entity/Q50071181

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Rationale and design of the 50 ...... lIadeL WAfer ImplaNT registry.

@en

Rationale and design of the 50 ...... lIadeL WAfer ImplaNT registry.

@nl

type

Item

label

Rationale and design of the 50 ...... lIadeL WAfer ImplaNT registry.

@en

Rationale and design of the 50 ...... lIadeL WAfer ImplaNT registry.

@nl

prefLabel

Rationale and design of the 50 ...... lIadeL WAfer ImplaNT registry.

@en

Rationale and design of the 50 ...... lIadeL WAfer ImplaNT registry.

@nl

P1476

Rationale and design of the 50 ...... lIadeL WAfer ImplaNT registry.

@en

P2093

Dellann Elliott Mydland

http://www.w3.org/2001/XMLSchema#string

Evan Scullin

http://www.w3.org/2001/XMLSchema#string

Jeffrey Olson

http://www.w3.org/2001/XMLSchema#string

Kevin O Lillehei

http://www.w3.org/2001/XMLSchema#string

Nina A Paleologos

http://www.w3.org/2001/XMLSchema#string

Steven N Kalkanis

http://www.w3.org/2001/XMLSchema#string

Tania Johnson

http://www.w3.org/2001/XMLSchema#string

Timothy Ryken

http://www.w3.org/2001/XMLSchema#string

P2860

Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review

Polymeric drug delivery for the treatment of glioblastoma

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Tumor treating fields: a novel treatment modality and its use in brain tumors

Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.

A randomized trial of bevacizumab for newly diagnosed glioblastoma

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.

P304

CNS08

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2217/CNS-2017-0036

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Linda Liau

P577

2017-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29206049

http://www.w3.org/2001/XMLSchema#string

P932

5977275

http://www.w3.org/2001/XMLSchema#string